Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This guy is a baffoon,...
He's a confused clown?
Funny you should mention him. He just posted this...
I hope and pray we can prove history wrong and fight a war on more than one boarder.
... And then they have the gaul to criticise others.
Frogs get no respect.
Must have had my crabby panties on this morning.
What a lousey thing to say.
Check out DynCorp's "accomplishments"...
http://en.wikipedia.org/wiki/DynCorp_International
Track tour...
tiptow?
That song came out in 1939? C'mon Fred. Don't date yourself.
==================
[Spoken]
Who's that walkin' 'round here?
Mercy!
Sounds like baby patter!
Baby elephant patter, that's what I calls it!
Say, up in Harlem,
At a table for two,
There were four of us,
Me, your big feet and you!
From your ankles up, I say you sure are sweet,
From there down, there's just too much feet!
Yas!
Your feet's too big!
Don't want ya 'cause your feet's too big!
Can't use ya 'cause your feet's too big!
I really hate ya 'cause your feet's too big!
Yeah!
Da-dee-do-dah, wan-ga-der!
Where'd you get 'em?
Nyah-da-dum!
Your girl, she likes you, she thinks you're nice,
Got what it takes to be in paradise;
She says she likes your face, she likes your rig,
But, man, oh, man, them things are too big!
Oh, your feet's too big!
Don't want ya 'cause your feet's too big!
Mad at you 'cause your feet's too big!
I hate you 'cause your feet's too big!
[Spoken]
My goodness, those are gunboats!
Shift! Shift! Shift!
Oh, your pedal extremities are colossal!
To me you look just like a fossil!
You got me walkin', talkin' and squawkin',
'Cause your feet's too big, yeah!
[Spoken]
Come on and walk that thing!
Oh, I never heard of such walkin'! Mercy!
Your... your pedal extremities really are obnoxious.
One never knows, do one?
Clem made Matt an MP? Nice touch.
You're looking at the wrong post. Do you think this is better than stem cell research? See #msg-19603478
Well, take a look please...it's a test of faith.
Think this is a better idea than stem cell research? #msg-19603478
And what company thinks embryonic stem cells have potential?
No point in handing it to you on a plate, is there? See #msg-19603658 Is it too much to read?
So that means your wife tells you where to go?
There are many things funded by the government I don't want to pay for either. Maybe the taxpayers should get "line item" vetoes? What's your idea to accomplish this?
If you lived in MA, you wouldn't be happy...
Odds high, funds sparse for stem cell researchers
Patrick's $1b offer a temporary boost
By Scott Allen, Globe Staff | May 11, 2007
For all the hype and hope surrounding stem cell research, most of the companies trying to develop treatments from these powerful cells live in a place Governor Deval Patrick this week called the "valley of death." It is a harsh place where neither the federal government nor private investors provide much support and small firms with limited funding struggle to figure out how to harness stem cells' extraordinary power.
No one knows that better than Dr. Thomas Okarma , whose company, Geron Corp., hopes next year to start the nation's first human tests of a treatment derived from embryonic stem cells. The California company has already spent years developing OPC1 as a possible therapy for spinal cord injuries. Researchers have had to inject 2,000 animals to show it was safe, grow the cells 75 times over to prove they could do it, and invent a needle to inject cells into the injury site. Even if human tests go well, federal approval probably won't happen for years. If tests go badly, foes of embryonic stem cell research are sure to pounce.
"The challenge . . . is not for the faint of heart or the light of purse," said Okarma, who says his company has invested more than $100 million in stem cell research to date.
The $1 billion life sciences initiative Patrick announced this week could provide a boost for stem cell companies that locate or start up in Massachusetts, in part by providing stable support through the many years it will take to realize the promise of stem cell treatments. Saying he intended to make the state the "capital of stem cell research on the planet," Patrick wants to set up an embryonic stem cell bank at the University of Massachusetts that would greatly reduce storage costs for the delicate cells and expand researchers' access to different types.
He proposed grants for lab equipment that could be used to work with the embryonic stem cells scientists are banned from studying with federally supported lab instruments, and grants to keep promising researchers from leaving the state.
The proposal would also provide a hand up from the "valley of death" in the form of short-term funding for companies to develop ideas until they can attract private investors, and possibly an actual "incubator" building where new stem cell companies could be housed. Many details of the 10-year plan remain to be decided, including how the money would be divided between stem cell research and other sciences, but stem cell researchers have been overwhelmingly positive about the assistance.
"This is really a long-term investment in Massachusetts not losing its premier role in life sciences," said John Auerbach, state public health commissioner.
But, even with the burgeoning aid from Massachusetts and other states, biotech executives at the BIO 2007 conference in Boston this week made it clear that researchers still face daunting hurdles in learning how to grow and manage both adult and embryonic stem cells and to get them to do something medically useful. Embryonic stem cell research is less than a decade old, they pointed out, and new fields of medicine typically take 20 years or more to produce results. One danger, several top stem cell scientists said, is that cash-strapped firms will rush into human testing before they answer basic questions, with potentially disastrous results.
Many stem cell pioneers "are dealing with things they don't know enough about to begin with, and then they're adding stuff to it," said Nancy Parenteau of Vermont-based Parenteau BioConsultants, referring to the growth enhancers and other chemicals that are used to manipulate stem cells. She noted that some researchers don't even know where the stem cells go once they're injected into a patient. She said the Massachusetts initiative could be great for the whole field if the state spurs more research on how stem cells work and why.
The Massachusetts investment could also discourage firms from following the lead of Advanced Cell Technology, a stem cell company that moved its corporate headquarters from Worcester to Alameda, Calif., a year and a half ago, partly to take advantage of California's Proposition 71, which made $3 billion available for stem cell research in that state over the next decade.
William M. Caldwell IV, Advanced Cell Technology chairman, called Patrick's move "long overdue," after former governor Mitt Romney's opposition to embryonic stem cell research. Now, Caldwell said, Massachusetts could have "the most user-friendly state from the standpoint of research and commercialization in the country." The company still has researchers in Worcester, and Caldwell said his firm may expand activities there.
Compared with most states, Massachusetts has a vibrant stem cell research community, led by the Harvard Stem Cell Institute, which has 45 principal faculty members and more than 600 employees involved in stem cell research at Harvard-affiliated hospitals and labs. But the number of companies in the state trying to develop treatments from adult or embryonic stem cells remains tiny, a problem Caldwell sees across the country. "It's like a desert," he said.
Embryonic stem cells have inspired hope and controversy since University of Wisconsin researchers first isolated them in 1998. The cells are the body's master cells, capable of becoming any kind of tissue, raising the possibility that they could be coaxed to create replacement tissue for diseased and damaged organs. But some argue that the harvesting of stem cells from fertilized human embryos is unethical because it requires the destruction of the embryo . In August 2001, President Bush sided with critics, banning US funding for research on embryonic stem cells harvested after that date.
As a result, unlike those in other new scientific fields, embryonic stem cell researchers got almost no boost from the federal government: Nationally, they received only $122 million from the National Institutes of Health from 2002 to 2006, roughly the amount Geron alone has spent on stem cell research. NIH did provide $799 million over the same period for stem cells taken from adults, but the requirement that older and newer embryonic stem cells be strictly segregated discouraged many researchers from entering the stem cell field at all. And overall NIH funding for stem cells has not increased for three years, resulting in a steady rise in the percentage of studies that are rejected.
For Geron, dwindling federal support means that whenever the company needs a question answered it has to pay for the research. Fortunately for the company, animal tests of its stem cell therapy for spinal damage, OPC1, have produced some of the most remarkable results yet in stem cell research, consistently restoring rats' ability to use their hind legs. Geron is now ready to ask the US Food and Drug Administration for permission to begin testing the treatment in humans.
But Goldstein, who was not involved in the OPC1 research, said the clarity of the Geron findings is a rare exception in a field full of ambiguities.
The fear among researchers is that poorly-thought-out experiments could go so badly that the results damage the field much the way the 1999 death of Jesse Gelsinger, a healthy teenager, cast a shadow over another promising treatment, gene therapy.
"The ideological right is not asleep," said Robert Klein , chairman of the Independent Citizens Oversight Committee in California, which oversees public stem cell funding. He cautioned that opponents of embryonic stem cell research will attempt to exploit setbacks in human trials. "There will be failures as well as successes. We must be patient."
Scott Allen can be reached at allen@globe.com.
http://www.boston.com/business/technology/biotechnology/articles/2007/05/11/odds_high_funds_sparse_f...
pretty big assumption their susie...........
I'm confoozed..."My Susie", "Your Susie", "Our Susie", and now she's "Their Susie"?
Here's the cure!
============================
Pope's Brazil tour: Reporter's diary
Pope Benedict XVI is making his first official visit to the Americas, with a trip to Brazil. BBC Rome correspondent David Willey is covering the visit and recording his thoughts in a daily diary.
WEDNESDAY, 9 MAY 2007
The 'miracle pill'
The highlight of the Pope's visit to Sao Paulo will be the canonisation ceremony of Brazil's first native-born saint.
His name was Brother Antonio Galvao and he lived two centuries ago in a rather modest monastery still standing among the skyscrapers in sprawling modern Sao Paulo, where he used to dispense a cure-all "pill" to people who sought his aid to relieve such painful illnesses as kidney stones.
These "pills" were made of tiny scraps of paper with a minute inscription - a prayer to the Virgin Mary in Latin - written on them and then scrunched up to be small enough to swallow whole.
Brother Antonio died in 1822 but his "pills" are still being dispensed by the 14 nuns who live cloistered lives in the convent that he originally built.
I had to travel 30 times back and forth across the Atlantic ... before those difficult Monsignori at the Vatican finally caved in and agreed to create our first native Brazilian saint
Sister Celia Cadorin
In fact, there has been a huge demand for them this week - 10,000 a day at the moment, as sainthood looms for their inventor.
The nuns no longer have the time to write out the Latin prayer inscriptions by hand. The tiny scraps of paper are cut from a printed sheet.
One man outside the convent told me that he had come along to get the "pills" for his mother, who was absolutely convinced that they work miracles.
I queued to get my three minuscule paper "pills", carefully hand-wrapped in a another tiny piece of white paper by these industrious nuns.
You almost need a magnifying glass to see them. I'm not quite sure if I shall take them or hoard them for some future undefined illness.
But Sister Celia Cadorin, the 70 year old Brazilian nun (in Vaticanese she is called the "postulator" of the cause of Brother Antonio) who brought about the successful conclusion of Brother Antonio's sudden final spurt to sainthood 185 years after his death, is justifiably proud about Friday's canonisation mass, which is expected to attract two million people.
She is a frequent flier.
In fluent Italian she told me: "Do you know I had to travel 30 times back and forth across the Atlantic from Sao Paulo to Rome to argue Brother Antonio's case before those difficult Monsignori at the Vatican finally caved in and agreed to create our first native Brazilian saint?"
Story from BBC NEWS:
http://news.bbc.co.uk/go/pr/fr/-/2/hi/americas/6639903.stm
Published: 2007/05/09 16:56:31 GMT
© BBC MMVII
Other than Bill Clinton?
Did Eilene post that?
Notice how there Pedophilia is popping up everywhere now......
Nice play on words.
...he's a winner in my book though my minds not made up yet
A Gemini?
Fair enough, but don't forget to read what you post, and listen to how it sounds.
That's bean counter jargon?
Kinda sucks, doesn't it, to see such a low percentage of registered voters actually vote? Wouldn't have taken much to swing the election the other way either. Guess we all have to abide by the rules, eh? Of course, we could whine about it, right?
New math...
The power of allocation?
Ah, bias, in whichever direction is something else; each side has the freedom to express itself. Is that not what free speech is?
I've offered you the opportunity to discuss this privately. Your thread is off-topic for this forum.
Yes, your question was answered: see #msg-19224481
Yes, and I see you chose not to answer my question there, or now. That, of course, is your prerogative.
Do you support free speech?
I wouldn't know what they think about you having freedom of speech. However, I guess they'd answer you if you posed the question directly to them.
BTW, are you a supporter of free speech?
That wasn't my understanding of their last two posts. Why don't you ask them directly?
The American left has enjoyed unchallenged freedom of speech for decades.
And has not the American right, in fact ALL Americans, enjoyed this same freedom?
New iBox. If the shoe fits...
Could be. Maybe he means Return On Equity. Where's Churak when you need him?
change the roe and IMPOSE a govt. in iraq
Not sure I understand this, but it sounds fishy.
And if, for medical reasons, the fetus jeopardized the life of the mother, would you therefore approve of an abortion?
Well, you're confirming my observation. You're pro-life for a fetus, but are for the state taking the life of an adult. Can you reconcile your viewpoint for me?
Well, not to get sidetracked on whether you are liberal or conservative or a religious conservative, since you appear to be pro-life, do you also support eliminating the death penalty?